Monitor proxy vote outcome — a dissident victory would signal board dissatisfaction but is unlikely. Watch for definitive proxy materials and voting recommendations from ISS/Glass Lewis. Near-term stock price may be range-bound with low volume given OTC listing and lack of new operational catalysts.
Price Chart
Executive Summary
Vaxart filed additional definitive proxy soliciting materials in connection with its 2026 Annual Meeting scheduled for July 16, 2026. Management is urging employees and shareholders to vote for its slate of six director nominees, opposing a dissident group led by Daniel P. Houle that seeks to replace half the board. The outcome likely favors management given the dissidents' small ownership (~0.7%) and perceived lack of relevant experience.
Key Facts
- Annual Meeting scheduled for July 16, 2026.
- Dissident stockholder Daniel P. Houle nominated three director candidates to replace three of six board seats.
- Board unanimously recommends voting FOR its six nominees, citing dissidents' lack of biotech expertise.
- New director James B. Breitmeyer appointed on April 23, 2026, strengthening the board ahead of the contest.
- Management sent an employee communication emphasizing the importance of supporting the current board.
- Prior preliminary proxy (PREC14A) filed May 19, 2026 indicates a formal proxy fight.
- Historical performance shows poor T+20 results for prior calls on VXRT (avg -8.55% at T+20, 25% win rate).
Financial Impact
No financial figures disclosed; proxy contest costs and potential distraction are immaterial compared to market cap.
Risk Factors
- Dissident could win significant institutional support if shareholders are dissatisfied with performance.
- Proxy fight may distract management from clinical milestones and operations.
- Low liquidity on OTC market could amplify any price moves on vote outcome.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-059237 |
| Document: 0001213900-26-059237-index-headers.html | 0001213900-26-059237 |
| Document: 0001213900-26-059237-index.html | 0001213900-26-059237 |
| Document: 0001213900-26-059237.txt | 0001213900-26-059237 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $0.4800 $0.5000 | ▲ +4.17% | ▲ +0.79% | $0.4400 (−8.33%) |
Jul 7, 2026 12w ago | 8-K | $0.5500 $0.6000 | ▲ +9.09% | ▲ +5.93% | $0.4400 (−20.00%) |
Jul 6, 2026 12w ago | DEFA14A | $0.6200 $0.5900 | ▼ −4.84% | ▼ −5.69% | $0.4400 (−29.03%) |
Jul 2, 2026 13w ago | DEFA14A | $0.6400 $0.5490 | ▼ −14.22% | ▼ −14.52% | $0.4400 (−31.25%) |
Jul 2, 2026 13w ago | 8-K | $0.6400 $0.5200 | ▼ −18.75% | ▼ −18.34% | $0.4400 (−31.25%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 26, 2026 13w ago | 8-K | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 16, 2026 15w ago | DEFA14A | $0.5600 $0.5300 | ▼ −5.36% | ▼ −6.21% | $0.4400 (−21.43%) |
Jun 8, 2026 16w ago | DEFA14A | $0.5800 $0.5502 | ▼ −5.14% | ▼ −6.53% | $0.4400 (−24.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access